U.S. markets open in 1 hour 48 minutes

Evofem Biosciences, Amphora a Potential New Birth Control, Analysts Review and Target

NEW YORK, NY / ACCESSWIRE / January 7, 2019 / Traders News Source, aleading independent equity research and corporate access firm focused on smalland mid-cap public companies is issuing a comprehensive report on Evofem Biosciences, Inc.(NASDAQ: EVFM), a clinical-stage biopharmaceutical company developing and commercializing products to address unmet needs in women's sexual and reproductive health.

Amphora is its lead Multipurpose Vaginal pH Regulator (MVP-R) product candidate, for non-hormonal birth control.

Financial data, analysts review, price target and more READ MORE

Copyand paste to your browser may be required to view the report - https://tradersnewssource.com/evofem/

Evofem is leveraging its proprietary Multipurpose Vaginal pH Regulator (MVP-R) to develop product candidates for multiple indications, including the prevention of pregnancy, the prevention of urogenital transmission of chlamydia and gonorrhea in women and the prevention of recurrent bacterial vaginosis.

The management believes that the women whose priorities are avoiding hormone, healthy living or who finds side effects of hormonal method unbearable are going to be very attracted to a more natural birth control option that EVFM is going to offer in MVP-R Amphora.

Moreabout the company timeline for upcoming milestones and catalysts READ MORE

Copyand paste to your browser may be required to view the report - https://tradersnewssource.com/evofem/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source